Clinical Report: Viral Infections and Blood-Brain Barrier Dysfunction

Overview

Viral infections such as HSV-1, varicella zoster virus, HIV, Japanese encephalitis virus, and SARS-CoV-2 can disrupt the blood-brain barrier (BBB), leading to neurologic complications. Mechanisms include direct viral neurotropism, immune-mediated damage, and systemic inflammation, with clinical assessment relying on biomarkers and imaging techniques.

Background

The blood-brain barrier (BBB) is a critical neurovascular structure composed of brain endothelial cells, pericytes, and astrocytes that regulates molecular and pathogen transit into the central nervous system. Viral infections can compromise BBB integrity, resulting in severe neurologic manifestations like encephalitis, meningitis, and microcephaly. Understanding the cellular and molecular mechanisms of BBB disruption is essential for developing neuroprotective therapies beyond antiviral treatments. Current clinical methods to assess BBB integrity include biomarker analysis and advanced imaging modalities.

Data Highlights

The incidence of herpes simplex encephalitis (HSE), a major viral cause of BBB disruption, is estimated at 1 per 100,000 to 150,000 people annually. Biomarkers such as the cerebrospinal fluid (CSF)/serum albumin quotient serve as indices of BBB permeability, while advanced imaging techniques like dynamic contrast–enhanced MRI provide quantitative assessments of BBB function. Biomarkers including GFAP, S100B, neurofilament light, and tau proteins are used to detect neuronal and astrocytic injury related to BBB damage.

Key Findings

• BBB integrity depends on the neurovascular unit components: brain endothelial cells, pericytes, and astrocytes, which maintain tight junctions and barrier function.
• Viral infections cause BBB breakdown via direct infection of CNS cells, Trojan horse mechanisms, or systemic inflammation leading to increased permeability.
• Clinical assessment of BBB disruption includes CSF/serum albumin ratio, blood biomarkers of neuronal and astrocytic injury, and dynamic contrast-enhanced MRI.
• Herpes simplex virus 1 is the most common cause of sporadic viral encephalitis, with significant BBB compromise and neurologic sequelae.
• Current therapies primarily target viral replication; however, neuroprotective strategies to preserve BBB integrity are needed to reduce neurologic morbidity.

Clinical Implications

Clinicians should consider BBB disruption in patients presenting with neurologic symptoms during viral infections and utilize biomarkers and imaging to assess barrier integrity. Therapeutic approaches should not only focus on antiviral treatment but also aim to protect or restore BBB function to minimize neurologic damage. Early recognition and intervention may improve outcomes in viral encephalitis and related CNS complications.

Conclusion

Viral infections significantly impact BBB integrity through multiple mechanisms, contributing to severe neurologic complications. Advancing clinical assessment and therapeutic strategies targeting BBB protection is critical to improving patient outcomes.

References

1. ID Translational Science Update, Viruses -- Investigating Viral Infections and Their Impact on the Blood-Brain Barrier